Abstract

Diltiazem 5% in Lipoderm, Veterinary

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2008 - Compounding for Hospice and Cancer Patients

Page(s): 67

Download in electronic PDF format for $75

Abstract

A formulation for preparing Diltiazem 5% in Lipoderm, Veterinary. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2003 Pg. 106-113	Veterinary Transdermal Medications: A to Z Author(s): Davidson Gigi S
Jan/Feb 2008 Pg. 67	Diltiazem 5% in Lipoderm, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 244	Diltiazem 5% in Lipoderm, Veterinary Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 392-397	Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Author(s): Mixon William, Helms Scott R
Nov/Dec 2020 Pg. 482-490	Stability of Compounded Diltiazem Hydrochloride in Cream, Ointment, and Gel Formulations for Topical Use Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Nov/Dec 2020 Pg. 501-508	Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Sep/Oct 2019 Pg. 428-433	The Current Landscape of Veterinary Compounding in the Veterinary Setting Author(s): Gochenauer Alexandria E, Rishniw Mark, Holmes Erin R, Forsythe Lauren R
Jul/Aug 2004 Pg. 269-274	Current Topical Treatments in Wound Healing - Part 1 Author(s): Helmke Christopher D
Nov/Dec 2018 Pg. 493	Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 241	Diltiazem Hydrochloride 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 422-427	The Current Landscape of Veterinary Compounding in the Pharmacy Setting Author(s): Gochenauer Alexandria E, Holmes Erin R, Barber Katie E, Forsythe Lauren R
Nov/Dec 2017 Pg. 446-452	Feline Transdermal Formulation Considerations Author(s): Forsythe Lauren Eichstadt
Sep/Oct 2014 Pg. 366-369	To Compound or Not to Compound: A Veterinary Transdermal Discussion Author(s): Eichstadt Lauren R, Davidson Gigi S
Jan/Feb 2016 Pg. 50	Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 149	Dexamethasone 2 mg/g Topical Paste, Veterinary Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 133	Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 242-246	Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats Author(s): Eichstadt Lauren R, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
Mar/Apr 2001 Pg. 86-88	The Use of Psychoactive Agents in Veterinary Medicine Author(s): Simpson Barbara S
Jan/Feb 2002 Pg. 43	Diltiazem HCl 2% Topical Gel Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 468-472	Unlicensed Transdermal Medications in Feline Patients: Three Case Reports Author(s): Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael